论文信息 - Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trial. - 字舞流文

Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trial.

Justine R. Smith | E. Suhler | J. Rosenbaum | L. Lim | S. Pasadhika | N. Butler | R. Beardsley | Shelly T. Lee | Tracy R. Giles | A. de Saint Sardos | Sirichai Pasadhika